EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update

by · The Cerbat Gem

EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) was the target of a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 1,589 shares, a decrease of 38.0% from the August 31st total of 2,561 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 41,368 shares, the short-interest ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of EUDA Health in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $55.00.

View Our Latest Stock Analysis on EUDA

EUDA Health Price Performance

Shares of EUDA opened at $15.79 on Friday. EUDA Health has a 12-month low of $5.26 and a 12-month high of $86.00. The firm has a 50-day moving average price of $15.59 and a 200 day moving average price of $13.73.

EUDA Health (NASDAQ:EUDA – Get Free Report) last issued its earnings results on Tuesday, September 29th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.57). The business had revenue of $1.73 million for the quarter, compared to the consensus estimate of $9.61 million.

About EUDA Health

(Get Free Report)

EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services.

Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions.

The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market.

Featured Stories